Phase 1 study of the safety and immunogenicity of a live, attenuated respiratory syncytial virus and parainfluenza virus type 3 vaccine in seronegative children (Q45363218)

From Wikidata
Jump to navigation Jump to search
scientific article published in February 2012
edit
Language Label Description Also known as
English
Phase 1 study of the safety and immunogenicity of a live, attenuated respiratory syncytial virus and parainfluenza virus type 3 vaccine in seronegative children
scientific article published in February 2012

    Statements

    Phase 1 study of the safety and immunogenicity of a live, attenuated respiratory syncytial virus and parainfluenza virus type 3 vaccine in seronegative children (English)
    David I Bernstein
    Elissa Malkin
    Nazha Abughali
    Judith Falloon
    Tingting Yi
    Filip Dubovsky
    MI-CP149 Investigators
    1 February 2012
    109-114

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit